On December 16, 2022, MoFo Partner and Co-Chair of Asia Private Equity practice, Thomas Chou, will speak at the panel “Trends, Opportunities, and Outlook for Biotech Investment” at BIOHK2022, an international convention organized by Hong Kong Biotechnology Organization to introduce novel state‑of-the-art biotech innovations from around the globe.
Moderated by Philip Law, Venture Capital & Private Equity Partner of Deloitte China, this panel will examine key trends, opportunities, and outlook for biotech investment in North Asia / China and Hong Kong. The topics will include:
Observations of the global investment market and its latest developments.
Differences between China, Europe, and U.S. investment trends and prospects.
The driving growth and unique opportunities in China's Biotech industry.
How does venture capital investing contribute to grooming young Biotech companies? What types of Biotech companies are attracting VC investment?
What can Hong Kong do additionally to become the best Global Investment Hub?
Other panelists include:
Simone Song, Founder and Senior Partner, ORI Capital;
Dr. Maggie Lo, Deputy Head Innovation and Technology, Invest Hong Kong; and
Samuel Siu, Senior Executive Director, Morgan Stanley.